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Abstract
Purpose Nitric oxide (NO) is a free radical synthesized mainly by nitric oxide synthases (NOSs). NO regulates many aspects in
sperm physiology in different species. However, in vitro studies investigating NOS distribution, and how NO influences sperm
capacitation and fertilization (IVF) in porcine, have been lacking. Therefore, our study aimed to clarify these aspects.
Methods Two main experiments were conducted: (i) boar spermatozoa were capacitated in the presence/absence of S-
nitrosoglutathione (GSNO), a NO donor, and two NOS inhibitors, NG-nitro-L-arginine methyl ester hydrochloride (L-NAME)
and aminoguanidine hemisulfate salt (AG), and (ii) IVF was performed in the presence or not of these supplements, but neither
the oocytes nor the sperm were previously incubated in the supplemented media.
Results Our results suggest that NOS distribution could be connected to pathways which lead to capacitation. Treatments showed
significant differences after 30min of incubation, compared to time zero in almost all motility parameters (P < 0.05).WhenNOSs
were inhibited, three protein kinase A (PKA) substrates (~ 75, ~ 55, and ~50 kDa) showed lower phosphorylation levels between
treatments (P < 0.05). No differences were observed in total tyrosine phosphorylation levels evaluated byWestern blotting nor in
situ. The percentage of acrosome-reacted sperm and phosphatidylserine translocation was significantly lower with L-NAME.
Both inhibitors reduced sperm intracellular calcium concentration and IVF parameters, but L-NAME impaired sperm ability to
penetrate denuded oocytes.
Conclusions These findings point out to the importance of both sperm and cumulus-oocyte-derivedNO in the IVF outcome in porcine.
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Introduction
Several reactive oxygen species (ROS), including hydrogen
peroxide, superoxide anion, and NO, have been shown to be
involved in processes important for sperm physiology. Under
normal, tightly regulated physiologic conditions, these ROS
are essential for the sperm to acquire the fertilizing ability [1].
At physiologic levels, NO has been demonstrated to modulate
sperm capacitation and acrosome reaction, and spermmotility,
and it may also have an anti-apoptotic effect (reviewed by [2]).
Besides, the importance of NO in oocyte maturation and sub-
sequent fertilization has also been revealed [3].
It is known that sperm can produce NO, but the evidence that
the endogenous synthesis is sufficient to be physiologically sig-
nificant is equivocal [4]. Various cell types in the mammalian
female reproductive tract generate substantial levels of NO,
which in turn determine the S-nitrosylation of sperm proteins.
Thus, in vivo is more likely to occur as a response to the NO
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generated by the female tract cells, rather than by autocrine
effects of sperm-generated NO. Furthermore, it has been dem-
onstrated that activity of NOSs, the enzymes responsible for NO
synthesis, can be modulated by sexual hormones [5]; therefore,
the NO levels will vary during the estrus cycle [6] which in turn
could regulate the fertilization process.
Sengoku et al. [7] showed that low concentrations of
NO may have a physiologic role in fertilization by en-
hancing the capacitation and binding to the zona pellucida
(ZP), but not by inducing the acrosome reaction or facil-
itating oocyte penetration. On the other hand, Herrero
et al. [8] showed that the incubation of spermatozoa with
NOS inhibitors reduced the IVF outcome in mouse. These
authors observed that NOS inhibition during sperm capac-
itation impaired the spontaneous acrosome reaction, as
well as the IVF. However, studies on the production of
certain substances during the interaction of gametes that
affect IVF performance have been scarce. In this sense, it
has been described that both spermatozoa and cumulus
cells produce NO and this molecule takes part in the fer-
tilization process [3, 9]. Nevertheless, despite all the stud-
ies carried out to determine the role of NO on sperm
function, we should improve our understanding of how
this gas modulates it by performing tests that bring us
closer to the physiological conditions during fertilization.
In relation to the studies using human spermatozoa and
their interaction with the female gamete, it has only been
possible to analyze hemizone binding assays [7, 10], log-
ically for ethical reasons. On the other hand, IVF assays
performed in mouse were done with epididymal sperma-
tozoa which cannot be considered physiologically mature.
Therefore, these studies, despite the important information
they provide, cannot be considered conclusive.
It appears that while NO synthesis in sperm is required for
IVF, the free radicals generated in the medium, including NO,
could be in excess and be harmful, as seen in certain infertility
cases [11]. In porcine, they could affect the functionality of
both spermatozoa and oocytes and, somehow, contribute to
the problem of polyspermy (i.e., fertilization of an ovum by
more than one spermatozoon) in this species. However,
polyspermy could be used as a tool to evaluate sperm func-
tionality since a higher percentage of penetrated oocytes and
sperm number per penetrated oocyte correlate with sperm
quality [12].
For all the reasons above, this paper aims to determine
the role of the NOS/NO system in the fertilizing capacity
of boar spermatozoa. Besides, since the NO function dur-
ing the fertilization process in porcine has not yet been
determined, we hypothesized that by regulating the NOS/
NO system, the IVF efficiency could be improved. To
develop this hypothesis, we determined, at first, the NO
effects on the spermatozoon, followed by its impact on
the IVF.
Materials and methods
Ethics
The study was carried out following the Spanish Policy
for Animal Protection RD 53/2013, which meets
European Union Directive 2010/63/UE on animal protec-
tion. The Ethics Committee of Animal Experimentation of
the University of Murcia and the Animal Production
Service of the Agriculture Department of the Region of
Murcia (Spain) (ref. no. A13160609) approved the proce-
dures performed in this work.
Materials
Unless otherwise stated, chemicals and reagents were pur-
chased from Sigma-Aldrich Química S.A. (Madrid,
Spain). Equine chorionic gonadotropin (eCG; Foligon)
was supplied by Intervet International B.V. (Boxmeer,
Holland), human chorionic gonadotropin (hCG; Veterin
Corion) by Divasa-Farmavic (Barcelona, Spain), and
Percoll by GE Healthcare (Uppsala, Sweden). The
prolonged anti-fade mounting medium (SlowFade
Antifade Kit) was obtained from Invitrogen (Paisley,
UK). NG-nitro-L-arginine methyl ester (L-NAME;
483125) was purchased from Calbiochem (distributed by
Merck Chemicals, Beeston, Nottingham, UK).
Culture media
In vitro maturation (IVM) of pig oocytes was carried out using
the NCSU-37 medium [13] supplemented with 0.57 mM cys-
teine, 1 mM dibutyryl-cAMP, 5 mg/mL insulin, 50 μM β-
mercaptoethanol, 10 IU/mL eCG, 10 IU/mL hCG, and 10%
v/v porcine follicular fluid.
Sperm capacitation and IVF were performed using
Tyrode’s albumin lactate pyruvate (TALP) medium [14],
consisting of 114.06 mM NaCl, 3.2 mM KCl, 8 mM Ca lac-
tate·5H2O, 0.5 mM MgCl2·6H2O, 0.35 mM NaH2PO4,
25.07 mMNaHCO3, 10 mMNa lactate, 1.1 mMNa pyruvate,
5 mM glucose, 2 mM caffeine, 3 mg/mL bovine serum albu-
min (BSA, A-9647), 1 mg/mL polyvinyl alcohol (PVA), and
0.17 mM kanamycin sulfate.
Sperm collection
Sperm samples were collected from boars with proven fertility
by the gloved hand method. Standard laboratory techniques
were applied to evaluate sperm concentration, motility, acro-
some integrity, and normal morphology.
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Immunocytochemistry: NOS detection and Tyr-P
by IIF
To determine NOS localization, a method adapted fromMeiser
and Schulz [15] was used. Briefly, ejaculated boar sperm were
washed with Dulbecco’s phosphate-buffered saline without cal-
cium chloride and magnesium chloride (DPBS) and spread on
glass slides coated with poly L-lysine. Spermatozoa were air-
dried and fixed for 20 min in ice-cold 3% v/v paraformaldehyde
in DPBS containing 120 mM sucrose. They were gently rinsed
with DPBS, incubated for 10 min in ice-cold 100% v/v metha-
nol, and triply washedwithDPBS. Specimenswere treatedwith
blocking I solution (10% w/v BSA, 1% v/v Triton X-100, dis-
solved in distilled water, 1 h, 20 °C). Next, sperm were incu-
bated with blocking II solution (2% w/v BSA, 1% v/v Triton
X-100, dissolved in distilled water, 1 h, 37 °C), which included
the primary anti-NOS antibodies (all three produced in mouse,
1:1000): anti-nNOS (N2280, monoclonal, clone NOS-B1, ob-
tained with a recombinant nNOS fragment [amino acids 1–181]
from rat brain), anti-eNOS (N9532, monoclonal, clone NOS-
E1, obtained with a synthetic peptide corresponding to bovine
eNOS [amino acids 1185–1205 with an N-terminally added
lysine] conjugated to keyhole limpet hemocyanin [KLH]), or
anti-iNOS (N9657, monoclonal, clone NOS-IN, obtained with
a synthetic peptide corresponding to iNOS from mouse macro-
phage [amino acids 1126–1144] conjugated to KLH). These
anti-NOS antibodies were chosen since their reactivity with
porcine sperm extracts was previously shown by Aquila et al.
[16]. Then, the specimens were triply washed with blocking II
and probed overnight (4 °C) with a FITC-labeled secondary
antibody (goat anti-mouse, 1:1000, diluted in blocking II). For
controls, specimens were processed in the absence of primary
and/or secondary antibody.
Tyrosine phosphorylation (Tyr-P) location was studied as pre-
viously described [17], using an anti-phosphotyrosine antibody
(4G10, Millipore, CA, USA, 1:300 in 1% w/v BSA). The sec-
ondary antibody was a fluorescein-conjugated goat anti-mouse
(Bio-Rad Laboratories, Madrid, Spain, 1:400 in 1% w/v BSA).
All images were taken at ×1000 (for NOS distribution) and
×400 (for Tyr-P location) magnifications, using the
AxioVision Imaging System (Rel. 4.8) with an AxioCam
HRc camera (Carl Zeiss, Göttingen, Germany) attached to a
Leica DMR fluorescence microscope (Leica Microsystems,
Wetzlar, Germany) equipped with a fluorescent optical blue
filter (BP 480/40; emission BP 527/30).
Spermatozoa motion assay
To evaluate sperm motility, computer-assisted sperm analysis
(CASA) was performed (ISAS® system, PROiSER R+D
S.L., Valencia, Spain), and the following parameters were
studied: total motility (%), progressive motility (%), curvilin-
ear velocity (VCL, μm/s), straight-line velocity (VSL, μm/s),
average path velocity (VAP, μm/s), linearity of the curvilinear
trajectory (LIN, ratio of VSL/VCL, %), straightness (STR,
ratio of VSL/VAP, %), amplitude of lateral head displacement
(ALH, μm), wobble of the curvilinear trajectory (WOB, ratio
of VAP/VCL, %), and beat cross-frequency (BCF, Hz). For
this purpose, a 4-μL drop of the sample was placed on a
warmed (38.5 °C) Spermtrack ST20 chamber (PROISER R+
D S.L) and analyzed using a phase-contrast microscope (×200
magnification; Leica DMR, Wetzlar, Germany). The setting
parameters were 60 frames at 30 frames/s, of which sperma-
tozoa had to be present in at least 15 to be counted.
Spermatozoa with a VCL less than 10 μm/s were considered
immotile. A minimum of five fields per sample were evaluat-
ed, counting a minimum of 200 spermatozoa per field.
Western blotting: PKAs-P and Tyr-P
Sperm protein extracts were isolated from 1 × 106
spermatozoa/sample and immunoblotted as described by
Navarrete et al. [18] with the following antibodies: anti-
phospho-PKA substrates (9624, Cell Signaling Technology,
Beverly, USA, 1:2000), anti-phosphotyrosine (4G10,
Millipore, CA, USA, 1:10000), and anti-β-tubulin (T0198,
Sigma-Aldrich®, Madrid, Spain, 1:5000). The Pierce® ECL
2 Western Blotting Substrate (80196, Lumigen Inc.,
Southfield, MI, USA) coupled with a chemiluminescence sys-
tem (Amersham Imager 600, GE Healthcare Life Sciences,
Buckinghamshire, UK) were used to visualize the blots. The
relative amount of signal in each membrane was quantified
using the ImageQuant TL v8.1 software (GE Healthcare).
Acrosome reaction assay
Boar spermatozoa were capacitated for 1 h and subsequently
exposed for 30 min to 3 ng/mL progesterone under different
experimental conditions, after which the percentage of
acrosome-reacted sperm was evaluated by staining with
FITC-conjugated peanut agglutinin from Arachis hypogaea
(PNA-FITC L7381, Sigma-Aldrich®, Madrid, Spain), as pre-
viously described [19]. Samples were analyzed under an
epifluorescence microscope at ×400 magnification.
Detection of membrane PS translocation
Translocation of phosphatidylserine (PS) residues to the outer
leaflet of the plasma membrane was detected with an Annexin
V-Cy3™ Apoptosis Detection Kit (Sigma, Madrid, Spain). For
this assay, 1 μL Annexin V with 5 μL 6-carboxyfluorescein
diacetate (6-CFDA) in 450 μL of binding buffer (commercial
kit) was mixed with 50 μL of each sperm sample. After 10 min
of incubation in the dark, at room temperature, samples were
fixed with 10 μL formaldehyde (10% v/v in DPBS). Each sam-
ple was placed on a slide and examined at ×400 magnification
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by epifluorescence microscopy. Viable sperm (6-CFDA+) were
visualized in green with a standard fluorescein filter and
Annexin+ sperm (labeling PS exposure, Annexin V-Cy3.18+)
in red (N2.1 filter; excitation BP 515–560 nm) [20].
Determination of [Ca2+]i
Intracellular calcium concentration ([Ca2+]i) was measured ac-
cording to a method reported previously [21, 22]. Specifically,
spermatozoa were incubated with 2.5 μMFura-2/AM in a buff-
er medium consisting of 2.7 mM KCl, 1.5 mM KH2PO4,
8.1 mM Na2HPO4, 137 mM NaCl, 5.55 mM glucose, and
1 mM pyruvate for 45 min at 37 °C. The extracellular unloaded
Fura-2 was removed by centrifugation (700×g, 5 min). Washed
sperm were resuspended in the same buffer to a concentration
of 3 × 108 cells/mL and incubated at 37 °C for 15 min in the
dark. Then, spermatozoa were centrifuged (700×g, 5 min) and
resuspended in TALP medium. As a negative control, sperma-
tozoa were also resuspended in DPBS. Fluorescence was mon-
itored using the Jasco FP-6300 spectrofluorometer (Jasco,
Madrid, Spain) for a further 30 min. Excitation wavelengths
alternated between 340 and 380 nm with emission held at
510 nm. At the end of the experiments, sperm were lysed with
0.5% v/v Triton X-100, and then Ca2+ was depleted by addition
of 25 mM EGTA. [Ca2+]i was calculated as previously de-
scribed [23]. For the statistical analysis, the Ca2+ concentration
(nM/L) was recorded from 0 to 1800 s at 30-s intervals for every
experimental group and replicate. Finally, the mean value dur-
ing the incubation period was calculated.
Oocyte collection and IVM
Ovaries from Landrace by Large White gilts were collected at a
local slaughterhouse (El Pozo Alimentación S.A., Alhama de
Murcia, Murcia, Spain) and transported within 30 min after
slaughter to the laboratory in saline solution containing 100 μg/
mL kanamycin sulfate at 38.5 °C. Before collecting the cumulus-
oocyte complexes (COCs), ovaries were washed once in 0.04%
w/v cetrimide solution and twice in saline. COCs from antral
follicles (3–6 mm diameter) were washed twice with DPBS sup-
plemented with 1 mg/mL PVA and 0.005 mg/mL red phenol,
and twice more in maturation medium previously equilibrated
for a minimum of 3 h at 38.5 °C under 5% CO2 in air. Groups of
50 COCswith complete and dense cumuli oophori were cultured
in 500μLmaturationmedium for 22 h at 38.5 °C under 5%CO2
in air. Following this incubation, COCs were washed twice in
fresh maturation medium without dibutyryl cAMP, eCG, and
hCG and cultured for an additional period of 20–22 h.
IVF and zygote staining
Following the 44 h culture in maturation medium, COCs were
stripped or not (see “Experimental design”) of cumulus cells by
pipetting and then washed three times with TALPmedium. The
IVF medium was previously equilibrated at 38.5 °C under 5%
CO2 in a four-well dish (250 μL/well), and groups of 50 oo-
cytes were transferred into each well. Semen aliquots (0.5 mL)
from different boars were mixed and subjected to a discontinu-
ous Percoll gradient (45 and 90% v/v, 740×g, 30 min). The
resultant sperm pellets were diluted in TALP medium and cen-
trifuged again (10 min at 740×g). After diluting the pellet again
in TALP, an aliquot of this suspension was used for IVF, giving
a final concentration of 2.5 × 105 spermatozoa/mL or 2.5 × 104
spermatozoa/mL, depending on the experiment. The IVF me-
dium was supplemented with NOS inhibitors or NO donor or
not supplemented, as described in the experimental design. At
18–20 h post-insemination, putative zygotes were fixed and
stained for evaluation as previously described [3].
Statistical analysis
The data are presented as the mean ± standard error of the
mean (SEM) and were tested for normality using the
Kolmogorov-Smirnov test, and the homogeneity of variance
was determined using the Levene test. ANOVAwas used for
the statistical analysis, and the means were separated using the
Tukey test at P < 0.05. Since the data regarding the acrosome
reaction experiment did not satisfy the Kolmogorov-Smirnov
and Levene tests, the Kruskal-Wallis test was applied, and
treatment average ranks were separated using the stepwise
step-down multiple comparisons method [24] at P < 0.05.
The true means of the data, rather than ranked means, are
presented. All statistical analyses were conducted using IBM
SPSS Statistics for Windows, Version 20.0 (IBM, Armonk,
NY, USA).
Experimental design
Experiment 1: effects of NO on sperm capacitation
To investigate how the NOS/NO system regulates sperm
functionality (Fig. 1: experiment 1), sperm samples were
incubated in TALP medium (capacitation medium) for
60 min at 38.5 °C and 5% CO2 with different treatments.
Four experimental groups were established according to the
treatment used: CONTROL: spermatozoa incubated in the
absence of any treatment; GSNO: spermatozoa incubated
in the presence of 100 μM S-nitrosoglutathione; L-NAME:
spermatozoa incubated in the presence of 10 mM NG-nitro-
L-arginine methyl ester hydrochloride; and AG: spermatozoa
incubated in the presence of 10 mM aminoguanidine
hemisulfate salt. These concentrations were chosen based
on a literature review [3, 4, 25].
The experimental groups mentioned above were sub-
jected to the following tests: indirect immunofluorescence
(IIF) (to determine NOS localization and Tyr-P in situ),
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Western blotting (WB) (to evaluate the phosphorylation of
PKA substrates and Tyr-P), acrosome reaction (AR) assay,
PS translocation assay, and measurement of [Ca2+]i.
However, to avoid sperm agglutination, which hinders
cell detection by CASA systems, and since previous stud-
ies have reported 30 min sperm incubation under capaci-
tation conditions were sufficient to observe changes in
sperm motility parameters [26], this period of time was
considered to be suitable to assess the effect of the NOS/
NO system on sperm motion.
Experiment 2: impact of NO on IVF
To assess how the NOS/NO system modulates the IVF in
porcine species, three experiments were performed (Fig.
1: experiment 2A, B, and C). All experiments were started
using in vitro matured oocytes, and IVF was performed
by adding to the medium the abovementioned NO donor
and NOS inhibitors. As a control group, IVF was per-
formed in the absence of any treatments. The spermatozoa
employed during IVF were not previously treated with
these supplements. The percentage of sperm penetration,
the sperm number per oocyte, the number of sperm bound
to the ZP, and the percentage of male pronucleus forma-
tion were determined in all experiments.
Experiment 2A: effects of NO on the interaction
between spermatozoa and COCs
IVF was performed using COCs that were co-incubated
with 2.5 × 105 spermatozoa/mL. The GSNO was used at a
concentration of 100 μM, whereas for the NOS inhibitors
(L-NAME and AG) the concentration was 10 mM. This
experiment was repeated five times, and a total of 549
oocytes were evaluated.
Experiment 2B: effects of NO on the interaction
between spermatozoa and decumulated oocytes
Since the cumulus cells also produce NO [27], this second
experiment was performed to investigate how the presence/
absence of NO alters the interaction between sperm and
decumulated oocytes. IVFwas performed using the same con-
centrations of NO donor and NOS inhibitors as in experiment
A. This experiment was repeated three times, and a total of
258 oocytes were evaluated.
Fig. 1 Analysis of the effects of a NO donor and two NOS inhibitors on
sperm capacitation and in vitro fertilization. Experimental design.
Experiment 1: Spermatozoa were incubated for 60 min in the presence
or not of these supplements. After that, the following assays were used to
evaluated sperm capacitation status: indirect immunofluorescence (IIF),
motility assay, Western blotting (WB), acrosome reaction (AR),
phosphatidylserine translocation (PS), and measurement of the
intracellular calcium concentration; Experiment 2: The in vitro
fertilization (IVF) was performed in the presence or not of the NO
donor and NOS inhibitors, under three circumstances: (A) Intact
cumulus-oocyte complexes and a sperm concentration of 250,000
spermatozoa/mL, (B) decumulated oocytes and a sperm concentration
of 25,000 spermatozoa/mL, and (C) lower concentrations of the NO
donor, NOS inhibitors, and spermatozoa. Neither the oocytes nor the
spermatozoa were treated with the NO donor or NOS inhibitors before
performing the IVF
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Experiment 2C: effects of low NOS inhibitor concentration
on the interaction between spermatozoa and decumulated
oocytes
The latter assay was developed to evaluate whether there is a
dose-dependent effect of the NO donor and NOS inhibitors.
For this, IVF was performed using decumulated oocytes,
2.5 × 104 spermatozoa/mL, and a lower concentration of NO
donor and NOS inhibitors (50 μM GSNO and 5 mM for the
inhibitors, respectively). This experiment was repeated three
times, and a total of 351 oocytes were evaluated.
Results
Experiment 1: effects of NO on sperm capacitation
NOS localization
The three isoforms of NOS, neuronal (nNOS), endothelial
(eNOS), and inducible NOS (iNOS), have been identified
in different mammalian spermatozoa, including the boar
[16]. However, to our knowledge no study has been
performed to localize NOSs in porcine ejaculated sperma-
tozoa. Therefore, we used IIF to identify the distribution
of these enzymes.
The eNOSwas identified in the acrosomal region, although
a weak fluorescent signal was also registered in the principal
and end piece of the flagellum (Fig. 2). Similarly, the nNOS-
associated fluorescence was concentrated in the sperm head
region, with a lower fluorescence in the principal and end
piece of the flagellum (Fig. 2). Moreover, immunofluorescent
iNOS staining was spread over the acrosomal, postacrosomal,
and neck region but also in the principal and end pieces of the
tail (Fig. 2).
Motility parameters
The role of NO in sperm motility is controversial, with
studies suggesting both a beneficial [28, 29] or detrimental
effect [30, 31].
When the CASA evaluation was performed in the present
study, at 0 min incubation time (Table 1), none of the motility
parameters showed statistical differences (P > 0.05). Later, at
30 min of incubation (Table 1), no differences were found for
total motility, progressive motility, VCL, LIN, STR, WOB,
Fig. 2 Localization of NOS isoforms by indirect immunofluorescence.
Spermatozoa were fixed, permeabilized, and incubated with specific anti-
eNOS, nNOS, and iNOS primary antibodies, together with a FITC-
labeled secondary antibody and examined under an epifluorescence
microscope at ×1000 magnification. Representative pictures are shown
by phase-contrast microscopy (a), merging the phase-contrast image with
the green fluorescence pattern (b) and for the immunofluorescent staining
(c). The eNOS- and nNOS-associated fluorescence was identified in the
sperm head region, with a lower staining in the principal and end pieces of
the tail. The iNOS staining pattern was spread over the acrosomal,
postacrosomal, and neck region but also in the principal and end pieces
of the flagellum
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ALH, or BCF. However, when the VSL was studied,
CONTROL and GSNO groups (17.2 ± 1.3 and 17.9 ± 1.8, re-
spectively) were found to be significantly different from AG
(11.8 ± 0.8), but no differences were observed with L-NAME
(16.4 ± 0.5). Continuing the sperm motion analysis, when we
analyzed VAP at 30min, both CONTROL and GSNO showed
the highest values (26.6 ± 1.8 and 26.9 ± 2.6, respectively),
which did not differ from the L-NAME group (25.5 ± 0.8)
but were significantly different from AG (19.7 ± 0.9).
When looking at the effect of incubation time on the CASA
parameters, we observed that at 30 min of incubation, all
treatments showed significant differences compared to their
values at time zero for total motility, progressive motility,
VCL, VSL, VAP, and BCF. The same difference was found
among all treatments in ALH, except for GSNO. Finally,
when we compared the values for LIN, STR, and WOB at
T = 30 min, the different treatments did not statistically differ
from their T = 0 min counterparts.
Protein kinase A substrates and tyrosine phosphorylation
The sperm capacitation process involves the early activation
of protein kinases and the inactivation of protein phosphatases
[32]. It has been reported that NO can modulate this process
through the activation of the cAMP/PKA pathway [33] and it
is directly involved in tyrosine phosphorylation by modulat-
ing both the cAMP/PKA and the extracellular signal-regulated
kinase (ERK) pathways (reviewed by [34]).
To determine the effects of the NO donor and NOS inhib-
itors on boar sperm capacitation, PKAs-P and Tyr-P were
analyzed and quantified by WB (Fig. 3). Our results showed
that the phosphorylation levels for PKAs-P were significantly
lower when using the NOS inhibitors than in the CONTROL
group (Fig. 3a, d), whereas the NO donor had no significant
effect. Interestingly, the analysis of the relative optical density
revealed the presence of three PKA substrate species of ap-
proximately 75, 55, and 50 kDa which seemed to possess a
specific pattern of phosphorylation (Fig. 3a, e). In detail, the
NO donor and NOS inhibitors lowered significantly the de-
gree of phosphorylation in the ~ 75- and ~ 50-kDa species
compared with their levels in the CONTROL (P < 0.05), but
in the ~ 55-kDa species this effect was evident only when the
capacitation took place in the presence of GSNO and AG
(P < 0.05).
On the other hand, when considering the phosphorylation
levels of tyrosine residues, no significant effects were ob-
served in the presence of both the NO donor and NOS inhib-
itors (Fig. 3b, f).
Tyr-P detection by IIF
A crucial event involved in capacitation and the acquisition of
fertilizing potential is protein Tyr-P [35]. Different spermTa
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subpopulations were identified within a sample according to
their degree of capacitation and hyperactivation (Table 2). No
significant differences were found between groupswith regard
to the four Tyr-P patterns analyzed (P > 0.05).
AR assay
Progesterone is known to induce the acrosome reaction in
capacitated sperm [36], so we determined how this process
might be modulated by NO in boar spermatozoa. The results
represented in Fig. 4 indicated that the GSNO and AG
treatments did not influence the percentage of acrosome-
reacted sperm when compared to the CONTROL. However,
L-NAME reduced significantly this percentage (P < 0.05).
PS translocation
In boar spermatozoa, the capacitating agents had been shown
to induce rapid changes in the membrane lipid architecture
such as the external exposure of PS, which is also commonly
recognized as a marker of apoptosis [37, 38]. As is considered
that NO participates in both processes, we decided to
Fig. 3 Effect of GSNO, L-NAME, and AG on PKA substrates (PKAs-P)
and tyrosine phosphorylation (Tyr-P). Sperm were incubated for 60 min
under capacitating conditions in the absence of any treatments
(CONTROL) or in the presence of GSNO, a NO donor, and L-NAME
and AG (both NOS inhibitors). (a, b) Sperm protein extracts were
analyzed for phosphorylation by Western blotting using anti-PKAs-P or
anti-Tyr-P as first antibodies, respectively. (c) β-Tubulin was used as a
protein loading control. For signal quantification, each lane was
normalized to its β-tubulin optical density value. (d–f) Relative amount
of signal quantified in each membrane using ImageQuant TL v8.1
software for PKAs-P and Tyr-P, respectively. In the d and f bar charts,
the lane axis represents the total amount of signal quantified in the four
groups. Different letters (a, b, c) indicate statistically significant
differences (P < 0.05) between groups
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investigate the involvement of NO in the PS translocation
during sperm capacitation.
The results (Fig. 5) showed that the NO donor had no
significant effect on PS externalization. In fact, both the
CONTROL and the GSNO groups reached similar levels of
PS translocation (37.67% and 38%, respectively). On the oth-
er hand, when using the NOS inhibitors, a significant differ-
ence was observed only with L-NAME which had a lower PS
level than both the GSNO and CONTROL groups (29.83%;
P < 0.05). Sperm viability was higher than 50% in all the
treatments (data not shown).
Determination of [Ca2+]i
The regulation of Ca2+ is a fundamental step during the capac-
itation process [39]; therefore, we monitored its levels before
and after our treatments (Fig. 6). During the period prior to the
addition of treatments (600 s), Ca2+ intake increased throughout
the incubation time. Treatment with GSNO did not affect
[Ca2+]i versus CONTROL. However, both inhibitors had an
effect on the spermatozoa; in fact, results showed that L-
NAME reduces abruptly the [Ca2+]i at a basal level, while with
AG the reduction is more gradual after its addition.
Experiment 2: impact of NO on IVF
NO is one of the components of the environment where fer-
tilization occurs and is generated by oviductal cells [40, 41],
oocytes, and cumulus cells [9, 42] but also spermatozoa [15,
43, 44]. Besides, NO is necessary for sperm capacitation to
occur [45]. However, it has been suggested that the sperm NO
production is low and most likely these cells encounter suffi-
cient NO levels to support capacitation inside the female gen-
ital tract [46]. For these reasons, we studied the effects of NO
on the IVF parameters with and without cumulus cells.
Experiment 2A: effects of NO on the interaction
between spermatozoa and COCs
The results (Table 3) showed that the inhibition of NO pro-
duction affected all IVF parameters. The percentage of oo-
cytes that had been fertilized in the presence of inhibitors
decreased. The AG inhibitor reduced the IVF parameters,
Table 2 Effects of NO on the
immunolocalization of protein
Tyr-P
Treatment Number Pattern I (%) Pattern II (%) Pattern III (%) Pattern IV (%)
CONTROL 8 10.8 ± 1.9 60.8 ± 9.2 28.5 ± 9.4 63.7 ± 9.7
GSNO 8 11.2 ± 2.3 53.2 ± 9.9 35.9 ± 9.1 64.3 ± 10.9
L-NAME 8 20.0 ± 6.6 46.4 ± 11.3 33.6 ± 11.3 63.0 ± 10.3
AG 8 10.9 ± 2.8 49.4 ± 11.3 39.8 ± 10.9 64.6 ± 8.2
Pattern I, low capacitation status (non-phosphorylated or head- and/or flagellum-phosphorylated spermatozoa);
pattern II, medium capacitation status (equatorial segment or equatorial segment and flagellum-phosphorylated
spermatozoa); pattern III, high capacitation status (equatorial segment and head- and/or flagellum-phosphorylated
spermatozoa); pattern IV, flagellum phosphorylation independent of phosphorylation in other locations
Number number of replicates
Fig. 4 Effect of GSNO, L-NAME, and AG on the acrosome reaction.
After being incubated in capacitating conditions for 60min in the absence
of any treatments (CONTROL) or in the presence of GSNO, a NO donor,
and L-NAME and AG (both NOS inhibitors), the sperm were exposed to
3 ng/mL progesterone during another 30 min under the different
experimental conditions. Next, the percentage of acrosome-reacted sperm
was evaluated by PNA-FITC staining. Different letters (a, b) indicate
statistically significant differences (P < 0.05) between groups
Fig. 5 Effect of GSNO, L-NAME, and AG on PS translocation.
Following incubation under capacitating conditions, the translocation of
PS residues was analyzedwith anAnnexin V-Cy3™Apoptosis Detection
Kit. Different letters (a, b) indicate statistically significant differences
(P < 0.05) between groups
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but these were higher than in the L-NAME group. As for the
number of spermatozoa bound to the ZP and the mean number
of spermatozoa per oocyte, we observed that they decreased
both with the use of GSNO and with NOS inhibitors. In all the
parameters analyzed, the NOS inhibitor with the greatest ef-
fect was L-NAME.
Experiment 2B: effects of NO on the interaction
between spermatozoa and decumulated oocytes
To verify that the effect of the inhibitors was not influenced by
the presence of cumulus cells, we decided to evaluate the IVF
outcome with denuded oocytes. The obtained results are
Fig. 6 Intracellular calcium concentration. Graphs show the
measurements collected from the different treatments: a control, b
GSNO, c L-NAME, and d AG. The excitation wavelengths are shown
with blue (340 nm) and green (380 nm) lines, while the intracellular
calcium concentration is shown by the red line. Fluorescence was
measured with the calcium indicator Fura-2/AM and monitored using a
spectrofluorometer for 40 min. The system was stabilized for 10 min
(dashed arrow) before adding or not the treatment
Table 3 Effects of NO during
IVF with intact cumulus-oocyte
complexes
Treatment Number Penetration (%) Sperm/oocyte (n) Sperm/ZP (n) MPN formation (%)
CONTROL 139 100a 7.8 ± 0.3a 61.9 ± 3.5a 100
GSNO 128 93.0 ± 2.3a 6.5 ± 0.4a,b 40.8 ± 2.6b 100
L-NAME 136 1.5 ± 1c 1.5 ± 0.5c 13.8 ± 1.7c 100
AG 146 57.5 ± 4.1b 2.5 ± 0.2b,c 13.7 ± 1.3c 100
Lowercase letters in the same column denote significant differences (P < 0.05) between groups
Number number of evaluated oocytes per group, MPN male pronucleus formation
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shown in Table 4, in which we can observe that there was no
penetration when the IVF medium was supplemented with L-
NAME and was very low when using AG. The addition of the
NO donor to the fertilization medium had no significant effect
on the percentage of penetration with respect to the
CONTROL group. As for the spermatozoa adhered to the
ZP, both the NO donor and the NOS inhibitors lowered this
parameter when compared to the CONTROL.
Experiment 2C: effects of low NOS inhibitors concentration
on the interaction between spermatozoa and decumulated
oocytes
Furthermore, we decided to analyze if IVF results would be
modified by decreasing the inhibitor concentration, as well as
that of spermatozoa (which synthesize NO). We observed
(Table 5) that the inhibitors continued to have the same effect
on all analyzed parameters. Also, with a lower sperm concen-
tration (2.5 × 104 spermatozoa/mL), the penetration percentage
in the CONTROL and in the GSNO groups was lower than in
our previous experiments, in which a 10-fold higher sperm
concentration was used.
Discussion
The participation of the NOS/NO system in the reproductive
function has been widely demonstrated [34]. NO has a dual
role. Low amounts, generated under physiological conditions,
seem to be beneficial for sperm functions [7, 28], but the
excessive synthesis of NO, which takes place under in vitro
fertilization conditions, could be detrimental for sperm func-
tion [47]. For that, the amount of NO in the fertilization media
is variable and depends on the cumulus cells or sperm produc-
tion, which could modify the capacitation process and the IVF
outcome. The present study is, to the best of our knowledge,
the first one to tackle both these aspects in porcine species, in
the effort to obtain more insight on NO-mediated gamete in-
teraction in vitro in this species.
NO synthesis takes place via L-arginine oxidation by three
distinct NOS isoforms: neuronal (nNOS), endothelial (eNOS),
also known as the constitutive isoforms, and the inducible
NOS (iNOS) [48]. Numerous studies have been conducted
to determine the presence and localization of these enzymes
in sperm from several species [34] with slight differences be-
tween them [15, 44, 49]. However, the localization in boar
sperm has not been described. We encountered a similar dis-
tribution between eNOS and nNOS, mostly in the sperm head
region, whereas the immunofluorescent iNOS staining was
spread on almost all sperm regions. This pattern could have
a physiological significance, and it may suggest that the con-
stitutive NOSs could be closely related to the activation of key
pathways which leads to the capacitation [49], while the gen-
eral distribution of the iNOS immunostaining might be con-
nected to inflammatory processes in the male reproductive
tract [50–52], rather than in the acquiring of the fertilization
ability. We do not know if the NOS pattern exhibited by boar
sperm changes during incubation in vitro, but this aspect
should be addressed in future studies.
In the porcine species, research was focused mainly to ad-
dress the involvement of NO in the promotion of capacitation
[16, 53–55], lacking studies addressing the effect on sperm
Table 4 Effects of NO during
IVF with denuded oocytes Treatment Number Penetration (%) Sperm/oocyte (n) Sperm/ZP (%) MPN formation (%)
CONTROL 61 98.4 ± 1.6a 8.3 ± 0.5a 41.2 ± 2.5a 98.3 ± 0.2a
GSNO 63 96.8 ± 2.2a 8.0 ± 0.5a 25.3 ± 1.3b 98.4 ± 0.2a
L-NAME 66 0 0 0.6 ± 0.1c 0
AG 68 17.6 ± 4.6c 1.8 ± 0.3b 5 ± 0.9c 100a
Lowercase letters in the same column denote significant differences (P < 0.05) between groups
Number number of evaluated oocytes per group, MPN male pronucleus formation
Table 5 Effects of NO during
IVF with lower concentrations of
sperm, NO donor, and NOS
inhibitors
Treatment Number Penetration (%) Sperm/oocyte (n) Sperm/ZP (n) MPN formation (%)
CONTROL 80 78.7 ± 4.6a 5.5 ± 0.9 42.8 ± 4.6a 96.8 ± 2.2
GSNO 76 77.6 ± 4.8a 7.2 ± 0.9 36.4 ± 3.9a 100
L-NAME 102 1.9 ± 1.4b 1.0 ± 0 5.0 ± 0.6b 100
AG 93 3.2 ± 1.8b 1.0 ± 0 4.9 ± 0.8b 100
Lowercase letters in the same column denote significant differences (P < 0.05) between groups
Number number of evaluated oocytes per group, MPN male pronucleus formation
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motility. In this sense, our results showed that despite that no
differences were found at the beginning of the incubation,
medium supplementation with AG, which selectively inhibits
iNOS [56], significantly reduced VSL and VAP at 30 min of
incubation. These results are completely opposite from the
ones reported by Alizadeh et al. in varicocelized rats [57],
where AG was shown to improve sperm motility and mito-
chondrial membrane potential. But both results are not com-
parable as their experimental design included an AG injection
daily for 10 weeks, while we treated ejaculated sperm for
30 min. Nevertheless, it is worth noting that the reduction in
these parameters has been linked to low breeding performance
in porcine species [58]. In relation to the lack of a visible effect
of the GSNO supplementation on sperm motility, this result
agrees with Zini et al. [46] in human sperm, who demonstrated
that a low concentration of a NO-releasing agent (0.1 mM),
equal to the one we used, had no effect on the percentage of
sperm motility or of hyperactivation. In regard to L-NAME,
we did not find any significant difference in our experiment,
while the addition of 10 mML-NAMEwas reported to inhibit
bull sperm progressive motility [25]. However, as some stud-
ies describe, this inhibitor is more likely to exert its effect on
the inhibition of sperm capacitation rather than affecting
sperm motility.
The phosphorylation levels of PKA substrates and tyrosine
are known to be indicative of sperm capacitation status [26]
and evidence confirms that NO regulates both serine/
threonine [59] and tyrosine phosphorylation [60]. Our data
suggest that the use of GSNO as a NO donor had no signifi-
cant effect on the total level of phospho-PKA substrates (i.e.,
serine and threonine phosphorylation) and phosphorylation of
tyrosine residues. On the contrary, Herrero and colleagues
[60] have suggested that NO-releasing molecules might accel-
erate the capacitation process. In fact, when using sodium
nitroprusside (SNP) during human sperm capacitation, an in-
crease in tyrosine phosphorylation was observed. Similarly,
Thundathil et al. [59] reported that the NO generated by
spermine NONOate leads to an increase in the phosphoryla-
tion levels of the threonine-glutamine-tyrosine motif in two
different human sperm proteins. However, we observed a spe-
cific phosphorylation pattern for three PKA substrate species,
~ 75, ~ 55, and ~ 50 kDa, which showed a lower degree of
phosphorylation in the presence of GSNO. These data also
seem to be in contrast with a previous work [61] and might
be explained by the difference in the capacitation time (60 min
in boar vs 240 min in human vs 90 min in mouse spermato-
zoa) and the species used, since the dynamics of serine/
threonine phosphorylation are species-specific [62, 63]. On
the other hand, our results showed that the inhibition of NO
synthesis leads to a decrease in the levels of phospho-PKA
substrates. This effect was more evident in the ~ 75- and ~ 50-
kDa species. We speculate that these bands might contain
proteins targeted for tyrosine phosphorylation, after they have
been phosphorylated in serine/threonine by PKA in the pres-
ence of NO [64] to allow the correct development of the ca-
pacitation process.
NO is able to determine an increase in Tyr-P via the sGC-
cGMP signaling pathway [34] at nanomolar levels [65] and
the lack of NO due to NOS inhibition is correlated with lower
levels of Tyr-P [60, 66]. However, according to our data, the
NOS inhibitors had no effect on Tyr-P. It is possible that nei-
ther the NO donor nor the inhibitors used in our study were
able to increase or lower Tyr-P because the low endogenous
NO levels were enough to induce it [67]. This result is sup-
ported by our Tyr-P immunolocalization data, where no dif-
ferences were observed between treatments.
At a molecular level, the AR shares a significant overlap
with molecular events of capacitation [48] and both processes
have been shown to be regulated by NO [46]. When incubat-
ing boar spermatozoa with exogenous NO, we did not observe
any differences when compared to CONTROL. Other studies,
however, report the NO donor’s ability to increase the percent-
age of acrosome-reacted sperm in boars [54] and different
species (human [68], buffalo [69], and mouse [61]). This dis-
crepancy might be explained by the different NO-releasing
molecule used in these studies, which have different kinetics
for NO generation [60]. Interestingly, when adding L-NAME
to the incubationmedium, the ARwas significantly reduced in
our study. This finding is consistent with previous studies in
boar [16, 54], human [60], and hamster spermatozoa [70],
which confirms that endogenous NO is necessary for sperma-
tozoa to achieve their full fertilizing ability [60].
The translocation of PS is considered a physiological event
during the capacitation process but also a sign of cellular dam-
age [20, 38]. During sperm capacitation, the bicarbonate-
stimulated protein phosphorylation pathway leads to the acti-
vation of phospholipid scramblase [37, 71] which results in
the exposure of PS at the outer membrane surface [37]. Our
results showed that the use of GSNO did not induce apoptotic-
like changes in sperm when compared to CONTROL. This
contrasts the findings of Moran et al. [72], and the reason
might be the different methodological approach, namely, the
use of a different NO-releasing compound and its concentra-
tion (100 μM GSNO vs 400 μM SNP). It has been reported
that an increase in Annexin-positive spermatozoa is related to
capacitation in boar semen [72] and that NOS inhibitors pre-
vent capacitation [70]. This is in accordance with our obser-
vations regarding the NOS inhibitor L-NAME,which lowered
significantly the percentage of Annexin-positive sperm.
In sperm, [Ca2+]i changes through two routes, either Ca
2+
ions are released from internal stores or transported into the
cell by sperm-specific membrane channels [62, 73]. Previous
studies have shown that NO can interact with different Ca2+
routes [74–76] also in spermatozoa [27]. In this sense, we
have investigated how the NOS/NO system regulates [Ca2+]i
in porcine sperm. The results showed changes only when
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NOS inhibitors were used, L-NAME having the most potent
effect. We hypothesized that in its presence, Ca2+ ions get
expelled quickly from spermatozoa mainly through the Ca2+
efflux pump, plasma membrane calcium ATPase 4 (PMCA4)
[77, 78], which is known to regulate NO signaling by down-
regulating the NOSs in murine sperm [77]. When using L-
NAME, the PMCA4-NOS interaction might not have taken
place, which in turn might have led PMCA4 to extrude the
cytosolic Ca2+. Further experiments are needed to test this
hypothesis.
Although it also affects the rest of the NOS isoforms, AG
preferentially inhibits the iNOS isoform [79], which could
explain why the reduction of [Ca2+]i when adding this inhib-
itor is not as pronounced as it is with L-NAME. Our results
suggest that in the beginning the Ca2+ output is compensated
by the Ca2+ which comes from the internal stores causing the
increase in [Ca2+]i. Once the internal stores are empty, [Ca
2+]i
begins to decrease until reaching levels similar to those ob-
tained with L-NAME. No significant differences were ob-
served in relation to the GSNO supplementation, suggesting
that NO contributes to the gradual increase in [Ca2+]i. This
effect may be observed as a consequence of NO-mediated S-
nitrosylation on sperm Ca2+ stores such as the ryanodine re-
ceptors [27, 80, 81]. Clearly, more experiments will be needed
to confirm these data.
We have shown that the inhibition of NO synthesis, mainly
by L-NAME, affects protein phosphorylation, acrosome reac-
tion, and Ca2+ fluxes. However, the best test that indirectly
evaluates sperm capacitation is the IVF [82], because only fully
capacitated sperm can bind to the ZP, undergo acrosome reac-
tion, and penetrate the oocyte’s plasma membrane.
Consequently, we studied the modulation of sperm capacitation
by NO in an IVF system under three circumstances: (i) IVF
with cumulus-oocyte complexes, (ii) IVF with denuded oo-
cytes, and (iii) denuded oocytes with reduced concentrations
of NO donor and inhibitors. The results showed that under these
three circumstances the tendency was the same; that is, in the
presence of NOS inhibitors, the number of spermatozoa ad-
hered to the ZP and the percentage of penetrated oocytes, and
the mean number of spermatozoa per penetrated oocyte de-
creased. In addition, this effect was more pronounced when
the L-NAME inhibitor was used.
Although it was proved that spermatozoa can synthesize
NO, the evidence that its synthesis is sufficient to be physio-
logically important is not very clear [83]. For this reason, the
first part of our IVF experiments was done with oocytes to-
gether with cumulus cells which generate significant amounts
of NO and, therefore, participate in the processes of capacita-
tion and fertilization [27]. Under these circumstances, we ob-
served that both NOS inhibitors (L-NAME and AG) de-
creased the penetration rate but in a different way: AG reduced
this parameter to half versus CONTROL, while L-NAME
reduced it almost to zero. This may lead us to believe that
the inhibitory effect of AG on NO production from cumulus
cells or spermatozoa is not total since AG is a less potent
inhibitor of the constitutive isoforms [79]. For this reason,
enough NO could still be produced by the constitutive iso-
forms thus allowing the capacitation in some spermatozoa.
In 2008, Hou et al. [54] observed that the addition of L-
NAME inhibited NO production by 30–40%, impairing the
ability of spermatozoa to undergo the acrosome reaction.
However, in our experiment, the addition of L-NAME de-
creased the penetration rate almost to zero, the AR levels
being also significantly reduced. Therefore, in these condi-
tions we could assume that NO synthesis was almost
completely abolished, which might be explained by the fact
that the inhibitor concentration used in our study was higher
than the one used by Hou and colleagues.
Since cumulus cells could be differently sensible to NOS
inhibitors, we considered performing IVF using denuded oo-
cytes. The results showed a big decrease in the penetration rate
with the AG inhibitor and zero penetration with L-NAME, so
in the first experiment, the cumulus cells even in the presence
of inhibitors were able to generate NO to allow sperm capac-
itation and fertilization. Finally, with the purpose of checking
if the results previously obtained were due to the high concen-
tration of NO donor and NOS inhibitors or a high number of
sperm in the medium, we decided to reduce these parameters.
We observed that the penetration in the CONTROL and
GSNO groups decreased, but it did not increase in the inhib-
itor groups. We can assume that NO sperm production contin-
ued being abolished. On the other hand, Leal et al. [25] ob-
tained a penetration rate of 70% in bovine with the same L-
NAME concentration. Perhaps in this species, the constitutive
NOSs in sperm are less sensible to this inhibitor. In other
species, such as human [10] or mouse [8], it has been shown
that the inhibitor effects of L-NAME were dose-dependent
and the oocyte penetration could be affected even without
modifications in the sperm capacitation parameters [10]. In
contrast to Francavilla et al. [10], who observed that constitu-
tive NOS play a role in the human sperm’s capacity to fuse
with oocyte but not in the ZP binding, our results showed that
even though the binding was not completely abolished, it de-
creased, so we can assume that the primary binding is less
affected by NO absence. Interestingly, the NO donor GSNO
lowered significantly the number of sperm bound to the ZP
when compared with the CONTROL in either presence or
absence of cumulus cells. A similar finding was reported by
Wu et al. [84], suggesting that physiologic levels of NO are
required for the binding process.
Conclusions
During the past years, many studies focused on the role of NO
in the physiology of reproduction. However, a clear
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investigation addressing the ability of the NOS/NO duo to
modulate/affect in vitro both sperm capacitation and their in-
teraction with the oocyte has been lacking in boars. The pres-
ent work strongly suggests the importance of a delicate regu-
lation of NOS enzymes during capacitation and IVF. NOS
distribution, evidenced here for the first time in porcine sper-
matozoa, might be linked to key factors in the acquisition of a
full fertilizing ability, such as protein phosphorylation, acro-
some reaction, and intracellular Ca2+ fluxes. Our data shows
how both sperm and cumulus-oocyte derived NO is required
for successful IVF. Nevertheless, further studies should pro-
vide more information on these mechanisms in the attempt to
solve IVF issues in porcine species, such as polyspermy.
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